Literature DB >> 22302795

The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination.

Holly Hung1, Rebecca Kohnken, John Svaren.   

Abstract

Several key transcription factors and coregulators important to peripheral nerve myelination have been identified, but the contributions of specific chromatin remodeling complexes to peripheral nerve myelination have not been analyzed. Chromodomain helicase DNA-binding protein 4 (Chd4) is the core catalytic subunit of the nucleosome remodeling and deacetylase (NuRD) chromatin remodeling complex. Previous studies have shown Chd4 interacts with Nab (NGFI-A/Egr-binding) corepressors, which are required for early growth response 2 (Egr2/Krox20), to direct peripheral nerve myelination by Schwann cells. In this study, we examined the developmental importance of the NuRD complex in peripheral nerve myelination through the generation of conditional Chd4 knock-out mice in Schwann cells (Chd4(loxP/loxP); P0-cre). Chd4 conditional null mice were found to have delayed myelination, radial sorting defects, hypomyelination, and the persistence of promyelinating Schwann cells. Loss of Chd4 leads to elevated expression of immature Schwann cell genes (Id2, c-Jun, and p75), and sustained expression of the promyelinating Schwann cell gene, Oct6/Scip, without affecting the levels of Egr2/Krox20. Furthermore, Schwann cell proliferation is upregulated in Chd4-null sciatic nerve. In vivo chromatin immunoprecipitation studies reveal recruitment of Chd4 and another NuRD component, Mta2, to genes that are positively and negatively regulated by Egr2 during myelination. Together, these results underscore the necessity of Chd4 function to guide proper terminal differentiation of Schwann cells and implicate the NuRD chromatin remodeling complex as a requisite factor in timely and stable peripheral nerve myelination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302795      PMCID: PMC3292862          DOI: 10.1523/JNEUROSCI.2895-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation.

Authors:  Kenichi Nishioka; Sergei Chuikov; Kavitha Sarma; Hediye Erdjument-Bromage; C David Allis; Paul Tempst; Danny Reinberg
Journal:  Genes Dev       Date:  2002-02-15       Impact factor: 11.361

3.  Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex.

Authors:  Philip Zegerman; Benito Canas; Darryl Pappin; Tony Kouzarides
Journal:  J Biol Chem       Date:  2002-02-15       Impact factor: 5.157

4.  Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice.

Authors:  C S Gillespie; D L Sherman; S M Fleetwood-Walker; D F Cottrell; S Tait; E M Garry; V C Wallace; J Ure; I R Griffiths; A Smith; P J Brophy
Journal:  Neuron       Date:  2000-05       Impact factor: 17.173

5.  Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10.

Authors:  N Bondurand; M Girard; V Pingault; N Lemort; O Dubourg; M Goossens
Journal:  Hum Mol Genet       Date:  2001-11-15       Impact factor: 6.150

6.  EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression.

Authors:  R Nagarajan; J Svaren; N Le; T Araki; M Watson; J Milbrandt
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

7.  Histone deacetylase activity is necessary for oligodendrocyte lineage progression.

Authors:  Mireya Marin-Husstege; Michela Muggironi; Aixiao Liu; Patricia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

8.  P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells.

Authors:  M L Feltri; M D'Antonio; S Previtali; M Fasolini; A Messing; L Wrabetz
Journal:  Ann N Y Acad Sci       Date:  1999-09-14       Impact factor: 5.691

9.  HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination.

Authors:  Ying Chen; Haibo Wang; Sung Ok Yoon; Xiaomei Xu; Michael O Hottiger; John Svaren; Klaus A Nave; Haesun A Kim; Eric N Olson; Q Richard Lu
Journal:  Nat Neurosci       Date:  2011-03-20       Impact factor: 24.884

10.  Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons.

Authors:  M Laura Feltri; Diana Graus Porta; Stefano C Previtali; Alessandro Nodari; Barbara Migliavacca; Arianna Cassetti; Amanda Littlewood-Evans; Louis F Reichardt; Albee Messing; Angelo Quattrini; Ulrich Mueller; Lawrence Wrabetz
Journal:  J Cell Biol       Date:  2002-01-03       Impact factor: 10.539

View more
  31 in total

1.  Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2.

Authors:  Ki H Ma; Holly A Hung; Rajini Srinivasan; Huafeng Xie; Stuart H Orkin; John Svaren
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

Review 2.  Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes.

Authors:  Wangzhi Li; Alea A Mills
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

3.  Epigenomic Regulation of Schwann Cell Reprogramming in Peripheral Nerve Injury.

Authors:  Ki H Ma; Holly A Hung; John Svaren
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

Review 4.  Chromatin remodeling and epigenetic regulation of oligodendrocyte myelination and myelin repair.

Authors:  Elijah Koreman; Xiaowei Sun; Q Richard Lu
Journal:  Mol Cell Neurosci       Date:  2017-12-15       Impact factor: 4.314

Review 5.  Transcriptional and Epigenetic Regulation of Oligodendrocyte Development and Myelination in the Central Nervous System.

Authors:  Ben Emery; Q Richard Lu
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-07-01       Impact factor: 10.005

6.  Zeb2: Inhibiting the inhibitors in Schwann cells.

Authors:  Bastian G Brinkmann; Susanne Quintes
Journal:  Neurogenesis (Austin)       Date:  2017-02-02

7.  Miz1 Controls Schwann Cell Proliferation via H3K36me2 Demethylase Kdm8 to Prevent Peripheral Nerve Demyelination.

Authors:  David Fuhrmann; Marco Mernberger; Andrea Nist; Thorsten Stiewe; Hans-Peter Elsässer
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

8.  Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.

Authors:  Li He; Q Richard Lu
Journal:  Neurosci Bull       Date:  2013-03-13       Impact factor: 5.203

9.  Multivalent recognition of histone tails by the PHD fingers of CHD5.

Authors:  Samuel S Oliver; Catherine A Musselman; Rajini Srinivasan; John P Svaren; Tatiana G Kutateladze; John M Denu
Journal:  Biochemistry       Date:  2012-08-08       Impact factor: 3.162

10.  Polycomb repression regulates Schwann cell proliferation and axon regeneration after nerve injury.

Authors:  Ki H Ma; Phu Duong; John J Moran; Nabil Junaidi; John Svaren
Journal:  Glia       Date:  2018-10-11       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.